Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Motohiro Tamiya

Showing results (81-90 of 192) with videos related to

Pageof 20
Sort By:
Thoracic Cancer|March 24, 2025
Real-World Efficacy and Safety of Lenvatinib in Advanced or Recurrent Thymic Carcinoma: A Multicenter Retrospective Study in JapanSatoshi Miyamoto, Akihiro Tsukaguchi, Hanako Kuhara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 23, 2015
[Evaluation of the Safety of a Generic Formulation of Cisplatin in Patients with Thoracic Malignancies]Yuki Ueda, Yoko Kondo, Hidekazu Suzuki, et al.
Cancer Medicine|November 19, 2017
Pretreatment advanced lung cancer inflammation index (ALI) for predicting early progression in nivolumab-treated patients with advanced non-small cell lung cancerTakayuki Shiroyama, Hidekazu Suzuki, Motohiro Tamiya, et al.
Anticancer Research|August 1, 2018
Clinical Characteristics of Liver Metastasis in Nivolumab-treated Patients with Non-small Cell Lung CancerTakayuki Shiroyama, Hidekazu Suzuki, Motohiro Tamiya, et al.
Plos One|December 17, 2013
Usefulness of high suction pressure for sufficient tissue collection during endobronchial ultrasound guided transbronchial needle aspirationTakayuki Shiroyama, Norio Okamoto, Hidekazu Suzuki, et al.
Medical Oncology (Northwood, London, England)|November 26, 2015
A phase II study of pemetrexed plus carboplatin followed by maintenance pemetrexed as first-line chemotherapy for elderly patients with advanced non-squamous non-small cell lung cancerMotohiro Tamiya, Akihiro Tamiya, Hiroyasu Kaneda, et al.
Anticancer Research|July 1, 2015
Evaluation of Bone Metastasis Using Serial Measurements of Serum N-Telopeptides of Type I Collagen in Patients with Lung Cancer: A Prospective StudyMotohiro Tamiya, Shinya Tokunaga, Hideaki Okada, et al.
Plos One|August 1, 2019
Clinical outcomes in non-small cell lung cancer patients with an ultra-high expression of programmed death ligand-1 treated using pembrolizumab as a first-line therapy: A retrospective multicenter cohort study in JapanRyuya Edahiro, Masaki Kanazu, Hiroyuki Kurebe, et al.
Clinical Lung Cancer|May 22, 2012
Clinical significance of the serum crosslinked N-telopeptide of type I collagen as a prognostic marker for non-small-cell lung cancerMotohiro Tamiya, Masashi Kobayashi, Osamu Morimura, et al.
BMC Pulmonary Medicine|December 2, 2023
Utility of needle biopsy in centrally located lung cancer for genome analysis: a retrospective cohort studyKei Kunimasa, Shingo Matsumoto, Keiichiro Honma, et al.
Pageof 20

Showing results (81-90 of 192) with videos related to

Sort By:
Pageof 20
Thoracic Cancer|March 24, 2025
Real-World Efficacy and Safety of Lenvatinib in Advanced or Recurrent Thymic Carcinoma: A Multicenter Retrospective Study in JapanSatoshi Miyamoto, Akihiro Tsukaguchi, Hanako Kuhara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 23, 2015
[Evaluation of the Safety of a Generic Formulation of Cisplatin in Patients with Thoracic Malignancies]Yuki Ueda, Yoko Kondo, Hidekazu Suzuki, et al.
Cancer Medicine|November 19, 2017
Pretreatment advanced lung cancer inflammation index (ALI) for predicting early progression in nivolumab-treated patients with advanced non-small cell lung cancerTakayuki Shiroyama, Hidekazu Suzuki, Motohiro Tamiya, et al.
Anticancer Research|August 1, 2018
Clinical Characteristics of Liver Metastasis in Nivolumab-treated Patients with Non-small Cell Lung CancerTakayuki Shiroyama, Hidekazu Suzuki, Motohiro Tamiya, et al.
Plos One|December 17, 2013
Usefulness of high suction pressure for sufficient tissue collection during endobronchial ultrasound guided transbronchial needle aspirationTakayuki Shiroyama, Norio Okamoto, Hidekazu Suzuki, et al.
Medical Oncology (Northwood, London, England)|November 26, 2015
A phase II study of pemetrexed plus carboplatin followed by maintenance pemetrexed as first-line chemotherapy for elderly patients with advanced non-squamous non-small cell lung cancerMotohiro Tamiya, Akihiro Tamiya, Hiroyasu Kaneda, et al.
Anticancer Research|July 1, 2015
Evaluation of Bone Metastasis Using Serial Measurements of Serum N-Telopeptides of Type I Collagen in Patients with Lung Cancer: A Prospective StudyMotohiro Tamiya, Shinya Tokunaga, Hideaki Okada, et al.
Plos One|August 1, 2019
Clinical outcomes in non-small cell lung cancer patients with an ultra-high expression of programmed death ligand-1 treated using pembrolizumab as a first-line therapy: A retrospective multicenter cohort study in JapanRyuya Edahiro, Masaki Kanazu, Hiroyuki Kurebe, et al.
Clinical Lung Cancer|May 22, 2012
Clinical significance of the serum crosslinked N-telopeptide of type I collagen as a prognostic marker for non-small-cell lung cancerMotohiro Tamiya, Masashi Kobayashi, Osamu Morimura, et al.
BMC Pulmonary Medicine|December 2, 2023
Utility of needle biopsy in centrally located lung cancer for genome analysis: a retrospective cohort studyKei Kunimasa, Shingo Matsumoto, Keiichiro Honma, et al.
Pageof 20